product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
ELISA/assay
product name :
FAM FLICA™ Caspase-2 Kit
catalog :
ICT918
quantity :
25 Tests
price :
308 USD
more info or order :
image
image 1 :
Bio-Rad ICT918 image 1
Both cells are apoptotic (green) and dying (blue nuclei). As the left cell is much brighter green than the right cell, the left cell had more active caspases
product information
Entity Type :
Kits
Entity Category :
Kits
ProductCode :
ICT918
Description :
FAM FLICA™ Caspase-2 Kit
Specificity :
Caspase-2
Format :
FAM (Green Fluorescence)
Conjugate/Tag :
FAM (Green Fluorescence)
Applications :
F,IF
ApplicationTypes :
Flow Cytometry,Immunofluorescence
Quantity :
25 Tests
Quantity Value :
25
Quantity Type :
Tests
Entity Formats :
FAM (Green Fluorescence)
UNSPSC :
41116126
PriceGBP :
220
PriceEUR :
308
PriceUSD :
308 USD
PriceCHF :
335
PriceSEK :
3357
PriceNOK :
3374
PriceDKK :
2296
NotForSaleInCountries :
KR
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.